Revolution Medicines, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RVMD Company Description
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
RVMD Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RVMD Smart Score
Score Breakdown
RVMD Company Description
Show More
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RVMD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RVMD's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of RVMD in WallStreetBets Daily Discussion
RVMD News
Recent insights relating to RVMD
CNBC Recommendations
Recent picks made for RVMD stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RVMD
Corporate Flights
Flights by private jets registered to RVMD
Our Analysis